Patent Law Weblog
recent posts
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs – Part II
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
about
Month: July 2009
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Max-Planck-Gesellschaft zur Frderung der Wissenschaften e.V. v. Wolf Greenfield & Sacks, P.C.1:09-cv-11168; filed July 9, 2009 in the District Court of Massachusetts…
-
July 14-15, 2009 – Pharma/Biotech Collaborative Agreements (American Conference Institute) – San Francisco, CA July 15, 2009 – Cost-Effective Patent Strategies (Law Seminars International) – Seattle, WA July 15, 2009 – Corporate Intellectual Property Conference (Law Bulletin Publishing Company) – Chicago, IL July 18-21, 2009 – National Association of Patent Practitioners (NAPP) 2009 Annual Meeting…
-
American Conference Institute (ACI) will be holding its fall session of the FDA Boot Camp conference on September 15-16, 2009 in Boston, MA. The conference will provide information on: • The organization, jurisdiction, functions, and operations of the FDA;• The essentials of the approval process for drugs, biologics, and devices, including: NDAs, 505b2s, INDs, 510…
-
The Center for Business Intelligence (CBI) will be holding its 3rd Summit on Biosimilars and Follow-on Biologics on September 14-15, 2009 in National Harbor, MD. The conference will address the multiple competing follow-on biologics bills that have been introduced in the current Congress and the impact of this legislation on the life sciences industry. CBI's…
-
American Conference Institute (ACI) will be offering a webinar entitled: "Pharmaceutical Antitrust Initiatives and Developments in the U.S. and Abroad" on July 29, 2009 from 1:00-2:30 PM (EST). Seth Silber of Wilson Sonsini Goodrich & Rosati and Jeffrey Brennan of Dechert LLP, both of whom were senior-level attorneys with the Federal Trade Commission, will provide…
-
By Donald Zuhn — On the same day that BIO CEO Jim Greenwood was briefing the media regarding follow-on biologics legislation in the current Congress, the National Coalition on Health Care (NCHC) was making its position on the legislation known in a letter sent to Senate Committee on Health, Education, Labor, and Pensions (HELP)…
-
By Kevin E. Noonan — Yesterday, Senator Ted Kennedy (D-MA) proposed that innovator biologic drugmakers should be given up to 13.5 years of data exclusivity in any follow-on biologics legislation to be considered by Congress this session. As reported by Catherine Larkin at Bloomberg.com, the Senator's proposal was introduced as a "placeholder" that could…
-
By Donald Zuhn — During a Wednesday afternoon teleconference, Jim Greenwood, the President and CEO of the Biotechnology Industry Organization (BIO), discussed a recent "flurry of activity" surrounding follow-on biologics legislation currently being debated in Congress. Noting that the Senate Committee on Health, Education, Labor, and Pensions had reported follow-on biologics legislation providing 12…
-
By Christopher P. Singer — On June 30, 2009, the U.S. Patent and Trademark Office sent out an e-Commerce e-Alert announcing that the World Intellectual Property Organization (WIPO) is now participating in the Priority Document Exchange (PDX) program. WIPO is the fourth foreign patent office (including Korea, Japan, and Europe) to join the PDX…
-
By Suresh Pillai — Stanford Graduate Student Adds Claims to Suit against Mentor and Professor over Patent Inventorship Christopher Sclimenti, a former graduate student in the laboratory of Stanford University faculty member Michele Calos, has amended his suit against both Stanford and his former mentor, claiming that Dr. Calos plagiarized Dr. Sclimenti's Ph.D. dissertation…
Patent Docs 